Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≥10-≤20
EC/CAS
112-34-5
Name of the chemical
2-(2-butoxyethoxy)ethanol
Concentration
≥1.0-≤5.0
EC/CAS
111-77-3
Name of the chemical
2-(2-methoxyethoxy)-ethanol
Concentration
≤1.0
General Information
Version
6
Revision date
2020-11-20
Product name
DEVFLX EGSHL PTB 4212-0200
1.2.1 Relevant identified uses
Consumer applications, Professional applications
Manufacturer Name
PPG Industries, Inc
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Classification of the TOXIC TO REPRODUCTION - Category 2 substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity 27.6% (oral), 7.7% (dermal), 29.6% (inhalation)
Signal word
Warning
Hazard statements
H361 - Suspected of damaging fertility or the unborn child.
Precautionary statements
General P102 - Keep out of reach of children. P101 - If medical advice is needed, have product container or label at hand.
Prevention
P201 - Obtain special instructions before use. P280 - Wear protective gloves, protective clothing and eye or face protection.
Response
P308 + P313 - IF exposed or concerned: Get medical advice or attention.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Other hazards which do not result in classification
Contains isothiazolinones. May cause allergic reaction. Emits toxic fumes when heated. See toxicological information (Section 11)
2.1 Classification of the substance or mixture
TOXIC TO REPRODUCTION - Category 2 substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 27.6% (oral), 7.7% (dermal), 29.6% (inhalation)
